Skip to main content
Bharat Parenterals Limited logo

Bharat Parenterals Limited — Investor Relations & Filings

Ticker · 541096 ISIN · INE365Y01019 LEI · 335800P94TEP45XMI742 BSE.NS Manufacturing
Open in API
Filings indexed 12 across all filing types
Latest filing 2026-06-03 Regulatory Filings
Country IN India
Listing BSE.NS 541096

About Bharat Parenterals Limited

https://www.bplindia.in/

Bharat Parenterals Limited specializes in the development, manufacture, and marketing of a diverse range of medicinal formulations. The organization operates advanced manufacturing facilities compliant with WHO-GMP standards, producing various dosage forms including small and large volume parenterals, tablets, capsules, liquid orals, dry syrups, and topical preparations. Its product portfolio addresses multiple therapeutic segments such as anti-infectives, cardiovascular, gastrointestinal, and analgesics. With a focus on research and development, the company maintains an extensive international presence, supplying products to markets across South East Asia, Africa, and Latin America. The company emphasizes quality assurance and regulatory compliance to deliver affordable healthcare solutions globally.

Recent filings

Filing Released Lang Actions
Please find the enclosed newspaper notice to the physical Shareholders informing them about the special Window for re lodge the transfer deed.
Regulatory Filings Classification · 85% confidence The document is a formal intimation under Regulation 30 of SEBI Listing Regulations, notifying the stock exchange of a newspaper advertisement to shareholders about re-lodgement of physical share transfer deeds. It is an exchange filing for compliance and does not contain substantive financial data or constitute any of the specified report types (e.g., annual report, earnings release, management change, etc.). It is therefore classified as a general regulatory announcement under the “Regulatory Filings” category (RNS).
2026-06-03 English
Annual Secretarial Compliance report for the Year ended March 31, 2026, Pursuant to regulations 24A of SEBI (LODR) Regulations, 2015.
Regulatory Filings Classification · 90% confidence The document is an Annual Secretarial Compliance Report issued under SEBI Listing Regulations (Reg. 24A), signed by a Practicing Company Secretary and submitted to the stock exchange. It is a statutory compliance certification rather than the company’s own Annual Report or financial statements, and does not detail management discussion or substantive financial data. Accordingly, it falls under a general regulatory/ compliance filing (RNS) as a fallback category for compliance certificates and regulatory disclosures.
2026-05-25 English
Newspaper publication of Audited Financial Results of the Quarter and Year ended on March 31, 2026.
Report Publication Announcement Classification · 95% confidence The document is a filing submitted to the stock exchange under SEBI’s Listing Obligations (Regulation 47), enclosing copies of a newspaper advertisement for the audited financial results (quarter and year ended March 31, 2026). It does not itself contain financial statements or detailed results but merely announces the publication of those results in the press and on the company’s website. This matches the “Report Publication Announcement” category, which covers notices that a report has been published or is available.
2026-05-21 English
Transcript of Earning Conference Call of Q4FY26.
Call Transcript Classification · 95% confidence The document is a full transcript of the company’s Q4 and FY ’26 earnings conference call (with moderator, opening remarks, financial results, and outlook), and it was submitted under Regulation 30. This matches the definition of a Call Transcript (CT).
2026-05-20 English
Audio Recording of Q4FY26 Earnings Conference Call
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange (BSE Limited) referencing Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements), which mandates disclosure of material events. The letter informs about the availability of the audio recording of the Q4FY26 earnings conference call, including a link to access the recording. The document does not contain the transcript or detailed financial data but only announces the availability of the audio recording. The document length is short (1368 characters), and it serves as a notification rather than the full transcript or report. Therefore, it fits the category of a Call Transcript announcement or related disclosure. However, since it only announces the audio recording and does not provide the transcript text itself, it is best classified as a Regulatory Filing (RNS) because it is a regulatory disclosure about the earnings call audio recording, not the transcript or detailed financial report itself.
2026-05-19 English
Investor Presentation for the Quarter and Year ended on March 31, 2026.
Investor Presentation Classification · 95% confidence The document is titled "INVESTOR PRESENTATION" and is provided pursuant to SEBI LODR Regulation 30, containing slide-style financial metrics, management commentary, segment disclosures, and strategic outlook for Q4 FY26 & Annual FY26. It is not merely an announcement but includes the full presentation content intended for investors. This matches the definition of an Investor Presentation (Code: IP).
2026-05-18 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.